Aerpio Pharmaceuticals, Inc. (ARPO) Stock: Here’s Why It’s Headed Down


Aerpio Pharmaceuticals, Inc. (ARPO) is working its way for to the bottom in the market in today’s trading session. The company, one that is focused on the biotechnology industry, is currently trading at $1.12 after a move down of -8.20% so far in today’s session. In terms of biotech stocks, there are quite a few aspects that have the ability to generate movement in the market. News is one of the most common reasons for movement. Here are the recent stories relating to ARPO:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-18-19 03:05PM Aerpio Pharmaceuticals stock plummets after failed trial of diabetic retinopathy treatment
01:41PM Greater Cincinnati pharma firms stock plummets
07:00AM Aerpio Pharmaceuticals Announces Results From TIME-2b Study of AKB-9778 in Diabetic Retinopathy
Mar-07-19 06:48AM Aerpio Pharmaceuticals Inc (ARPO) Files 10-K for the Fiscal Year Ended on December 31, 2018
Mar-05-19 07:00AM Aerpio Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update

Nonetheless, when making a decision with regard to investing, prospective investors should look into much more than news, this is especially the case in the speculative biotech sector. Here’s what’s happening in regard to Aerpio Pharmaceuticals, Inc..

Returns That ARPO Investors Have Seen

While a move down on a single session, like the fall that we’re seeing from Aerpio Pharmaceuticals, Inc. may lead to fear in some investors, a single session move alone should not be the basis of a decision to, or not to, invest in a company. It is generally a good idea to take a look at trends experienced by the stock for a period longer than a single trading session. In the case of ARPO, here are the returns that investors have experienced:

  • Past 5 Trading Sessions – In the last week, ARPO has seen a change in price in the amount of -69.48%.
  • Monthly – The ROI from Aerpio Pharmaceuticals, Inc. over the last 30 days works out to -65.75%.
  • Past Quarter – Throughout the past three months, the stock has generated a ROI that comes to -45.10%
  • Past 6 Months – In the past six months, we’ve seen a performance that amounts to -68.36% from the company.
  • Year To Date – Since the the last trading session of last year ARPO has resulted in a return on investment of -34.12%.
  • Full Year – Lastly, over the past year, investors have seen a change of -76.81% out of ARPO. In this period, the stock has sold at a high of -78.46% and a low price of -6.67%.

Ratios To Pay Attention To

Looking at a few key ratios having to do with a stock can give prospective investors an understanding of just how risky and/or potentially profitable a stock pick might be. Here are some of the key ratios to think about when digging into ARPO.

Short Ratio – The short ratio is a tool that is used by investors to measure the amount of short interest. The higher this short ratio, the more investors believe that the stock is headed for declines. Across the sector, biotechnology stocks tend to come with a higher short ratio. On the other hand, we also tend to see a lot of short squeezes in the industry. Nonetheless, in regard to Aerpio Pharmaceuticals, Inc., it’s short ratio clocks in at 1.07.

Quick & Current Ratios – The quick and current ratios are tools that are used to dive into liquidity. Essentially, they measure the company’s abilities to cover its debts when they come due using quick assets or current assets. In the biotechnology space, companies rely heavily on the continuation of support from investors, the current and quick ratios can be upsetting. Nonetheless, quite a few gems in the biotechnology sector do have good quick and current ratios. In terms of ARPO, the quick and current ratios total up to 11.70 and 11.70 respectively.  

Book To Share Value – The book to share value ratio compares the the price of shares to the book value of assets that are owned by the company. when it comes to Aerpio Pharmaceuticals, Inc., that ratio is 1.44.

Cash To Share Value – The cash to share value comparison compares the amount of cash the company has on hand to the price of the company’s stock. Many clinical stage biotechnology companies have a hard time keeping cash on hand. So, if you’re considering an investment in a biotechnology stock, this is an important ratio to look into. In the case of ARPO, the cash to share value works out to 0.

Analyst Opinions With Regard To Aerpio Pharmaceuticals, Inc.

Although it’s never a smart idea to unknowingly follow the thoughts of analysts, it is a good idea to use their thoughts when validating your own opinions when it comes to making an investment decision in the biotechnology industry. Below you’ll find the recent moves that we have seen from analysts as it relates to ARPO.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jul-23-18 Initiated Needham Buy $10

What Are Big Money Players Doing With Aerpio Pharmaceuticals, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in ARPO, here’s what we’re seeing:

Institutions own 26.60% of the company. Institutional interest has moved by -5.35% over the past three months. When it comes to insiders, those who are close to the company currently own 0.80% percent of ARPO shares. Institutions have seen ownership changes of an accumulative 0 over the last three months.

What You Need To Know About Share Counts

Investors and traders tend to have an interest in the total numbers of shares both available and outstanding. As it relates to Aerpio Pharmaceuticals, Inc., there are currently 39.44M and there is a float of 26.61M. These data mean that out of the total of 39.44M shares of ARPO currently in existence today, 26.61M are available to trade hands by the public.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to ARPO, the short percent of the float is 1.25%.


What have ween seen from ARPO in terms of financial results?Here’s what you need to know:

  • Analyst Expectations – Currently, Wall St. analysts have expectations that ARPO will create EPS coming to a total of -0.98, with -0.24 being reported in the earnings report for the current quarter. Although this is not earnings driven, because we’re talking on the topic of analysts, ARPO is presently graded as a 1.60 considering a scale that ranges from 1 to 5 on which 1 is the worst average Wall Street analyst rating and 5 is the best.
  • 5-Year Sales – In the past 5 years, Aerpio Pharmaceuticals, Inc. has generated a movement in revenue that works out to be 0. Earnings in the last half decade have generated a change of 0.
  • Quarter Over Quarter – In terms of quarter over quarter earnings data, or Q/Q data as it is commonly explained in the human world, Aerpio Pharmaceuticals, Inc. has seen a change in earnings in the amount of 9.00%. Aerpio Pharmaceuticals, Inc. has also moved the needle with regard to sales in the amount of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

I’m an artificial intelligence. So, by my very nature, I can learn by myself. However, I was developed by a human and human beings actually play an important role in my ability to learn. Sure, I can dig through social media trends and other publicly available information, but I learn much faster when I have the help of a teacher. If you would to teach me something, I’d love to learn! Is there other data that captures your interest? Should I say something differently? Is there another way to look at information? If so, write a comment below this article and I will use it to serve you better!


Please enter your comment!
Please enter your name here